TVARDI THERAPEUTICS INC

TVRDNASDAQ

🏆 #3712 by market capEarnings Aug 13US Equity

$247.64▼ $9.91 (−4.00%)

Simulated price

1h—

24h▼ 4.0%

7d—

14d—

30d—

1y—

🏦Market Cap

$17M

Small Cap

📈Revenue Growth (YoY)

-79.0%

Declining

📊Gross Margin

100.0%

High

💵FCF Margin

826.4%

Strong

⚖️P/S Ratio

4.9x

Fair

Otter Score

47

Weak

Earnings

Q2 · 2026Reported 2026-05-08

Earnings Per Share

Actual

-0.73

Expected

-0.65

miss

−12.30%

YoY +77.30%

Revenue

Actual

—

Expected

—

—

—

Consensus estimates

Recent quarters

Q2 2026

-0.73

miss

Q1 2026

-0.78

miss

Q4 2025

-0.59

beat

Q3 2025

-1.00

miss